These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3727715)

  • 1. Clotting properties in diverse valve prostheses.
    Zöller H; Gross W; Rieke K
    Z Kardiol; 1986; 75 Suppl 2():338-40. PubMed ID: 3727715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses.
    Horstkotte D; Schulte H; Bircks W; Strauer B
    J Heart Valve Dis; 1993 May; 2(3):291-301. PubMed ID: 8269122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of valve type and valve function on chronic intravascular hemolysis after alloprosthetic mitral and aortic valve replacement].
    Horstkotte D; Aul C; Seipel L; Körfer R; Budde T; Schulte HD; Bircks W; Loogen F
    Z Kardiol; 1983 Feb; 72(2):119-31. PubMed ID: 6845808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
    Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
    J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 7. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: ten-year follow-up.
    Bryan AJ; Rogers CA; Bayliss K; Wild J; Angelini GD
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):614-22. PubMed ID: 17320553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and hemolytic features of the St. Jude Medical valve prostheses.
    Sezai Y; Umeda S; Okazaki T; Okamoto I; Rikukawa H; Shiono M
    J Cardiovasc Surg (Torino); 1984; 25(1):16-24. PubMed ID: 6707068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-year comparison of tissue and mechanical valve replacement.
    Khan SS; Trento A; DeRobertis M; Kass RM; Sandhu M; Czer LS; Blanche C; Raissi S; Fontana GP; Cheng W; Chaux A; Matloff JM
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):257-69. PubMed ID: 11479498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prosthetic valves or tissue valves--a vote for mechanical prostheses.
    Horstkotte D
    Z Kardiol; 1985; 74 Suppl 6():19-37. PubMed ID: 4096074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological versus mechanical valves. Analysis of 1,116 valves inserted in 1,012 adult patients with a 4,818 patient-year and a 5,327 valve-year follow-up.
    Hammond GL; Geha AS; Kopf GS; Hashim SW
    J Thorac Cardiovasc Surg; 1987 Feb; 93(2):182-98. PubMed ID: 3807394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of thrombocyte aggregation after heart valve replacement].
    von Schacky C
    Z Kardiol; 1998; 87 Suppl 4():46-55. PubMed ID: 9857467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
    Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Late complications following Björk-Shiley and St. Jude Medical heart valve replacement].
    Horstkotte D; Körfer R; Budde T; Haerten K; Schulte HD; Bircks W; Loogen F
    Z Kardiol; 1983 May; 72(5):251-61. PubMed ID: 6880335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical heart valves: an insight into thrombotic complications.
    Bharat V
    Indian Heart J; 1999; 51(1):59-63. PubMed ID: 10327781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of valve replacement in children.
    Schaff HV; Danielson GK
    Cardiovasc Clin; 1986; 16(2):427-36. PubMed ID: 3742534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolysis parameters of St. Jude Medical: Hemodynamic Plus and Regent valves in aortic position.
    Suedkamp M; Lercher AJ; Mueller-Riemenschneider F; LaRosee K; Tossios P; Mehlhorn U
    Int J Cardiol; 2004 May; 95(1):89-93. PubMed ID: 15159044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.